Insider Transactions in Q3 2023 at Mineralys Therapeutics, Inc. (MLYS)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 06
2023
|
Jon Congleton Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,250
+0.21%
|
$27,000
$12.08 P/Share
|
|
Aug 17
2023
|
Jon Congleton Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,250
+0.22%
|
$27,000
$12.1 P/Share
|
|
Aug 11
2023
|
Jon Congleton Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+0.19%
|
$24,000
$12.89 P/Share
|
|
Aug 11
2023
|
David Malcom Rodman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
157,091
-100.0%
|
$1,885,092
$12.81 P/Share
|
|
Aug 11
2023
|
David Malcom Rodman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
157,091
+50.0%
|
$0
$0.81 P/Share
|
|
Aug 10
2023
|
David Malcom Rodman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
74,625
-100.0%
|
$970,125
$13.16 P/Share
|
|
Aug 10
2023
|
David Malcom Rodman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
74,625
+50.0%
|
$0
$0.54 P/Share
|